Carregant...
Biomarkers in the Assessment of Therapies for Familial Amyloidotic Polyneuropathy
The identification of specific biomarkers provides opportunities to develop early diagnostic parameters, monitor disease progression, and test drug efficiency in clinical trials. We previously demonstrated that in familial amyloidotic polyneuropathy (FAP) related to the abnormal extracellular tissue...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
ScholarOne
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2017105/ https://ncbi.nlm.nih.gov/pubmed/17932549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/2007-00068.Macedo |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|